Drug allergy to antibiotics. Part II. Management of patients with respiratory diseases and allergy to β-lactam antibiotics, diagnosis of hypersensitivity

16 листопада 2024
151
УДК:  616-071:[612.014.46:612.017.3]
Резюме

The high frequency of drug allergy cases determines the importance of identifying patients with a high risk of its development on antibiotics, primarily penicillins and cephalosporins, since it is drugs of these classes in real clinical practice that are most often prescribed by doctors of various specialties as initial empiric antibacterial therapy for patients with upper and lower respiratory infections ways. The key to the rapid detection of persons from the high-risk group of developing hypersensitivity reactions to medicinal products at an outpatient appointment is the collection by a doctor of an allergy history of each patient to whom it is planned to prescribe one or another drug, especially an antibiotic for bacterial respiratory infections. If a drug allergy to antibiotics or other drugs is suspected, the patient should be referred to an allergist or pediatric allergist for consultation. Traditionally, the diagnostic approach in case of drug allergy involves the use of the following research methods: 1) clinical and anamnestic data; 2) skin tests with medicinal products (in vivo tests); 3) laboratory tests with them (in vitro tests); 4) provocative tests with drugs (if necessary). It is not necessary to make a diagnosis of drug allergy only on the basis of laboratory tests, a large part of which is not validated in Ukraine, to condemn patients to a life-long «label» of such a diagnosis based only on the data of laboratory tests, and to deprive them of the opportunity to be effectively treated with drugs that are not causally significant. Macrolides can be a rational alternative to β-lactams in patients with respiratory infections and drug allergy.

References

  • 1. Зайков С.В. (2024) Медикаментозна алергія на антибіотики. Частина І. Поширеність, механізми розвитку, клініка, лікування, профілактика. Укр. мед. часопис, 5(163): 87–94. DOI: 10.32471/umj.1680-3051.163.256577.
  • 2. Picard M., Bégin P., Bouchard H. et al. (2013) Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J. Allergy Clin. Immunol. Pract., 1(3): 252–257. doi: 10.1016/j.jaip.2013.01.006.
  • 3. Blumenthal K.G., Shenoy E.S., Varughese C.A. et al. (2015) Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. Ann. Allergy Asthma Immunol., 115(4): 294–300.
  • 4. Cavkaytar O., Karaatmaca B., Cetinkaya P.G. et al. (2017) Characteristics of drug-induced anaphylaxis in children and adolescents. Allergy Asthma Proc, 38(5): 56–63.
  • 5. Yaytokgil S.B., Selmanoglu A., Kulhas I. et al. (2024) Evaluation of the frequency and characteristics of drug hypersensitivity reactions in hospitalized children: Real life-cohort study. World Allergy Organization J., 17: 100893.
  • 6. Min-Hye K., Dong Yoon K., Young-Hee N. et al. (2023) Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry World Allergy Organization J., 16: 100738.
  • 7. Lemiengre M.B. et al. (2012) Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews, 10: CD006089.
  • 8. Rosenfeld R.M. et al. (2015) Clinical practice guideline (update): adult sinusitis. Otolaryngol. Head Neck Surg., 152 (2S): 1–39.
  • 9. Fokkens W.J., Lund V.J., Mullol J. et al. (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology, 29: 1–464.
  • 10. Albert R.H. (2010) Diagnosis and treatment of acute bronchitis. Am. Fam. Physician, 82(11): 1345–1350.
  • 11. Березняков И.Г. (2018) Краткий справочник по эмпирическому использованию антибиотиков с лечебной и профилактической целью. Київ: ТОВ «НВП «Інтерсервіс»: 81–121.
  • 12. Зайков С.В. (2019) Тактичні питання раціонального застосування антибіотиків в амбулаторній практиці. Здоров’я України, 3(448): 16–21.
  • 13. Настанова (2019) «Негоспітальна пневмонія у дорослих осіб: етіологія, патогенез, класифікація, діагностика, антибактеріальна терапія та профілактика. Адаптована клінічна настанова, заснована на доказах». НАМН України: 94 c.
  • 14. Уніфікований клінічний протокол первинної, спеціалізованої та екстреної медичної допомоги «Хронічне обструктивне захворювання легень». 2024, 47 c.
  • 15. Наказ МОЗ України від 13.10.2023 р. № 1793 Про затвердження Уніфікованого клінічного протоколу первинної та спеціалізованої медичної допомоги «Гострий риносинусит», Уніфікованого клінічного протоколу первинної та спеціалізованої медичної допомоги «Хронічний риносинусит».
  • 16. Попович В.І. (2015) Гострий бактеріальний риносинусит. Сучасні погляди на етіопатогенез, діагностику та лікування. Медична газета «Здоров’я України», тематичний номер «Пульмонологія, Алергологія, Риноларингологія», 3(31): 12–14.
  • 17. Butler C.C., Hood K., Verheij T. et al. (2009) Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ, 338: b2242. DOI: doi.org/10.1136/bmj.b2242.
  • 18. Smith S.M., Fahey Т., Smucny J., Becker L.A. (2017) Antibiotics for acute bronchitis. Cochrane Database of Syst. Rev., 6: CD000245.
  • 19. Management and treatment of common infections — antibiotic guidance for primary care: for consultation and local adaptation (2017). PHE, 26 September 2017.
  • 20. National Institute for Health and Clinical Excellence (2008, 2018) Respiratory tract infections (self-limiting): prescribing antibiotics. NICE guideline (CG69).
  • 21. Wang J.X., Zhang S.M., Li X.H. et al. (2016) Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial. Int. J. Infect. Dis., 48: 40–45.
  • 22. Vollenweider D.J., Jarrett H., Steurer-Stey C.A. et al. (2012) Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., 12: CD010257.
  • 23. Miravitlles M., Kruesmann F., Haverstock D. et al. (2012) Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis. Eur. Respir. J., 39(6): 1354–1360.
  • 24. Llor C., Moragas A., Miravitlles M. et al. (2022) Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis. Pulm. Pharmacol. Ther., 72: 102111.
  • 25. SHARP Antimicrobial Stewardship Program (Last Updated Oct 2017).
  • 26. Torres M.J., Blanca M. (2010) The complex clinical picture of β-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems and clavams. Med. Clin. N. Am., 94: 805–820.
  • 27. Castells М., Khan D.A., Phillips Е.J. (2019) Penicillin Allergy. New Engl. J. Med., 381(24): 2338–2381.
  • 28. Наказ МОЗ України від 30.12.2015 р. № 916 «Уніфікований клінічний протокол екстреної, первинної, вторинної (спеціалізованої) та третинної (високоспеціалізованої) медичної допомоги «Медикаментозна алергія, включаючи анафілаксію».
  • 29. Наказ МОЗ України від 23.08.2023 р. № 1513 Стандарт медичної допомоги «Раціональне застосування антибактеріальних і антифунгальних препаратів з лікувальною та профілактичною метою».
  • 30. Brockow K., Garvey L.H., Aberer W. et al. (2013) ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs — an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy, 68(6): 702–712.
  • 31. Khan D.A., Banerji A., Blumenthal K.G. et al. (2022) Drug allergy: a 2022 practice parameter update. J. Allergy Clin. Immunol., 150(6): 1333–1393.
  • 32. Vyles D., Adams J., Chiu A. et al. (2017) Allergy testing in children with low-risk penicillin allergy symptoms. Pediatrics, 140(2): e20170471.
  • 33. Gerace K.S., Phillips E. (2015) Penicillin allergy label persists despite negative testing. J. Allergy Clin. Immunol. Pract., 3(5): 815–816.
  • 34. Castells M., Khan D.A., Phillips E.J. (2019) Penicillin Allergy. N. Engl. J. Med., 381: 2338−2351.
  • 35. Torres M.J., Blanca M. (2010) The complex clinical picture of β-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems and clavams. Med. Clin. N. Am., 94: 805–820.
  • 36. Pichichero M.E., Zagursky R. (2014) Penicillin and cephalosporin allergy. Ann. Allergy Asthma Immunol., 112(5): 404–412.
  • 37. Romano A., Gaeta F., Valluzzi R.L. et al. (2015) IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J. Allergy Clin. Immunol., 136(3): 685–691.
  • 38. Romano A., Gaeta F., Arribas Poves M.F., Valluzzi R.L. (2016) Cross-reactivity among beta-lactams. Curr. Allergy Asthma Rep., 16(3): 24.
  • 39. Caruso C., Valluzzi R.L., Colantuono S. et al. (2021) β-Lactam Allergy and CrossReactivity: A Clinician’s Guide to Selecting an Alternative Antibiotic. J. Asthma Allergy, 14: 31–46.
  • 40. Piotin A., Godet J., Jason A., Trubiano J.A. et al. (2022) Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule. Ann. Allergy Asthma Immunol., 128: 27−32.
  • 41. Demoly P., Adkinson N.F., Brockow K. et al. (2014) International Consensus on drug allergy. Allergy, 69: 420–437.
  • 42. Romano A., Blanca M., Torres M.J. et al. (2004) ENDA; EAACI. Diagnosis of nonimmediate reactions to β-lactam antibiotics. Allergy, 59(11): 1153–1160.
  • 43. Mayorga C., Celik G., Rouzaire P. et al. (2016) In Vitro Tests for Drug Allergy Task Force of EAACI Drug Interest Group. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy, 71(8): 1103–1134.
  • 44. Ariza A., Mayorga C., Fernandez N.D. et al. (2015) Hypersensitivity reactions to β-lactams: relevance of hapten-protein conjugates. J. Investig. Allergol. Clin. Immunol., 25(1): 12–25.
  • 45. Hausmann O.V., Gentinetta T., Bridts C.H., Ebo D.G. (2009) The basophil activation test in immediate-type drug allergy. Immunol. Allergy Clin. North Am., 29(3): 555–566.
  • 46. Hjortlund J., Mortz C.G., Stage T.B. et al. (2014) Positive serum specific IgE has a short halflife in patients with penicillin allergy and reversal does not always indicate tolerance. Clin. Transl. Allergy, 4: 34.
  • 47. Haw W.Y., Polak M.E., McGuire C. et al. (2016) In vitro rapid diagnostic tests for severe drug hypersensitivity reactions in children. Ann. Allergy Asthma Immunol., 117(1): 61–66.
  • 48. Gamboa P.M., García-Avilés M.C., Urrutia I. et al. (2004) Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests. J. Investig Allergol. Clin. Immunol., 14(4): 278–283.
  • 49. Fontaine C., Mayorga C., Bousguet P.J. et al. (2007) Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy, 62(1): 47–52. doi: 10.1111/j.1398-9995.2006.01268.x.
  • 50. Porebski G., Pecaric-Petkovic T., GrouxKeller M. et al. (2013) In vitro drug causality assessment in Stevens-Johnson syndrome — alternatives for lymphocyte transformation test. Clin. Exp. Allergy, 43(9): 1027–1037.
  • 51. Rive C.M., Bourke J., Phillips E.J. (2013) Testing for drug hypersensitivity syndromes. Clin. Biochem. Rev., 34(1): 15–38.
  • 52. Trautmann A., Seitz C.S., Stoevesandt J., Kerstan A. (2014) Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited. Clin. Exp. Allergy, 44(12): 1531–1538.
  • 53. Tanvarasethee B., Buranapraditkun S., Klaewsongkram J. (2013) The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems. Acta Derm. Venereol., 93(1): 66–69.
  • 54. Blanca M., Romano A., Torres M.J. et al. (2009) Update on the evaluation of hypersensitivity reactions to betalactams. Allergy, 64: 183–193.
  • 55. Norton A.E., Konvinse K., Phillips E.J., Broyles A.D. (2018) Antibiotic allergy in pediatrics Pediatrics, 141(5): e20172497.
  • 56. Devchand M., Trubiano J.A. (2019) Penicillin allergy: a practical approach to assessment and prescribing. Australian Prescriber, 42(6): 192–199.
  • 57. Mill C., Primeau M.N., Medoff E. et al. (2016) Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr., 170(6): e160033.
  • 58. Whyte A.F., Soar J. et al. (2022) Emergency treatment of anaphylaxis: concise clinical guidance. Clin. Med. (Lond.), 22(4): 332–339.